Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Basile

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Applied Health Economics and Health Policy|July 25, 2018
Cost-Effectiveness Analysis of Early Treatment of Chronic HCV with Sofosbuvir/Velpatasvir in ItalyMatteo Ruggeri, Federica Romano, Michele Basile, et al.
Frontiers in Public Health|August 8, 2022
Economic Aspects in the Management of Diabetic Macular Edema in ItalyGiovanna Elisa CalabrĂ², Michele Basile, Monica Varano, et al.
Global & Regional Health Technology Assessment|February 6, 2026
Erratum in: Economic evaluation of distribution modalities for ostomy and incontinence medical devices within the Italian healthcare contextAgostino Fortunato, Michele Basile, Debora Antonini, et al.
Global & Regional Health Technology Assessment|January 14, 2026
Agostino Fortunato, Michele Basile, Debora Antonini, et al.
Frontiers in Cardiovascular Medicine|April 2, 2024
A budget impact model and a cost-utility analysis of reducer device (Neovasc) in patients with refractory anginaAgostino Fortunato, Ilaria Valentini, Filippo Rumi, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Michele Basile, Filippo Rumi, Marco Palmeri, et al.
Journal of Medical Economics|April 27, 2026
Cost-effectiveness analysis of lorlatinib as first-line treatment for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in ItalyIlaria Valentini, Filippo Rumi, Eugenio Di Brino, et al.
Journal of Medical Economics|April 21, 2025
An Italian cost-utility analysis of 20-valent pneumococcal conjugate vaccine for routine vaccination in infantsMichele Basile, Filippo Rumi, Agostino Fortunato, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 26, 2025
Cost-effectiveness of treatments for presymptomatic newborn patients with spinal muscular atrophy and two or three copies of the survival motor neuron 2 gene in ItalyIlaria Valentini, Gianni Ghetti, Marika Pane, et al.
International Journal of Technology Assessment in Health Care|March 2, 2023
The added value of applying a disinvestment approach to the process of health technology assessment in ItalyChiara Cadeddu, Luca Regazzi, Eugenio Di Brino, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Applied Health Economics and Health Policy|July 25, 2018
Cost-Effectiveness Analysis of Early Treatment of Chronic HCV with Sofosbuvir/Velpatasvir in ItalyMatteo Ruggeri, Federica Romano, Michele Basile, et al.
Frontiers in Public Health|August 8, 2022
Economic Aspects in the Management of Diabetic Macular Edema in ItalyGiovanna Elisa CalabrĂ², Michele Basile, Monica Varano, et al.
Global & Regional Health Technology Assessment|February 6, 2026
Erratum in: Economic evaluation of distribution modalities for ostomy and incontinence medical devices within the Italian healthcare contextAgostino Fortunato, Michele Basile, Debora Antonini, et al.
Global & Regional Health Technology Assessment|January 14, 2026
Agostino Fortunato, Michele Basile, Debora Antonini, et al.
Frontiers in Cardiovascular Medicine|April 2, 2024
A budget impact model and a cost-utility analysis of reducer device (Neovasc) in patients with refractory anginaAgostino Fortunato, Ilaria Valentini, Filippo Rumi, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Michele Basile, Filippo Rumi, Marco Palmeri, et al.
Journal of Medical Economics|April 27, 2026
Cost-effectiveness analysis of lorlatinib as first-line treatment for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in ItalyIlaria Valentini, Filippo Rumi, Eugenio Di Brino, et al.
Journal of Medical Economics|April 21, 2025
An Italian cost-utility analysis of 20-valent pneumococcal conjugate vaccine for routine vaccination in infantsMichele Basile, Filippo Rumi, Agostino Fortunato, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 26, 2025
Cost-effectiveness of treatments for presymptomatic newborn patients with spinal muscular atrophy and two or three copies of the survival motor neuron 2 gene in ItalyIlaria Valentini, Gianni Ghetti, Marika Pane, et al.
International Journal of Technology Assessment in Health Care|March 2, 2023
The added value of applying a disinvestment approach to the process of health technology assessment in ItalyChiara Cadeddu, Luca Regazzi, Eugenio Di Brino, et al.
Pageof 5